INS and COVID-19: Another recent study confirmed other previous studies that revealed that the insulin/insulin-like growth factor 1 (IGF) signaling pathway, which plays an important role in energy metabolism, is impaired in organs and tissues of severe COVID-19 patients (Shin et al., 2022).